THERANOS INVESTOR ALERT: Hagens Berman Investigating

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
THERANOS INVESTOR ALERT: Hagens Berman Investigating Possible Securities Law Violations by Theranos, Inc. and its Officers

SAN FRANCISCO, Oct. 10, 2016 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP is continuing its investigation of possible securities law violations by Theranos, Inc. and its management.

If you are an investor in Theranos financing rounds and suspect you have lost money, contact Hagens Berman Sobol Shapiro LLP.  For more information visit:

https://www.hbsslaw.com/cases/Theranos

or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing   Theranos@hbsslaw.com .

Our initial investigation indicates that Theranos may have made significant misrepresentations about the state of the Company’s technology and operations when it solicited investments.

On October 6, 2016, the Wall Street Journal reported Theranos would shut down its blood-testing facilities and dismiss more than 40% of its employees after regulators banned Theranos CEO Elizabeth Holmes from owning or operating a lab for two years.

“We’re probing Theranos’s relationships with investors, the representations made to them, and this apparently self-interested shift in business strategy,” said Hagens Berman partner Reed Kathrein.  ”Sources indicate that Theranos sold stock in a Series C round to investor in 2014 and 2015. Normally, by the time of a Series C round, the technology or product is proven and the funds are used to expand the products’ presence in the market.”

Whistleblowers: Persons with non-public information regarding Theranos should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the SEC whistleblower program, whistleblowers who provide original information may receive rewards up to 30 percent of any successful recovery made by the SEC. For more information concerning your whistleblower options, call Reed Kathrein at (510) 725-3000 or email Theranos@hbsslaw.com .

About Hagens Berman Hagens Berman is headquartered in Seattle, Washington with offices in 10 cities. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the Firm and its successes can be found at www.hbsslaw.com . Read the Firm’s Securities Newsletter , and visit the blog . For the latest news visit our newsroom or follow us on Twitter at @classactionlaw .

Contact: Reed Kathrein, 510-725-3000

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Apple Watch Unveils Blood Pressure Feature for Users

Updated Category News Views 390

Revolutionary Hypertension Alerts in Apple Watch Ultra 3 Apple Inc. has recently launched the Apple Watch Ultra 3. This innovative device, now available for pre-order, is set to transform how users manage their health, particularly with its new blood pressure alert feature. FDA Approval: A Milestone for Apple Watch In an exciting move, the U.S. Food and Drug...

Continue Reading
Chartbeat Strengthens Media Operations with FatTail Purchase

Updated Category News Views 281

Chartbeat Expands Services Through Strategic Acquisition Chartbeat, a prominent player in media operations software, has made significant strides in its mission to enhance its service offerings. The acquisition of FatTail, an innovative advertising revenue management platform, marks a pivotal moment in Chartbeat's journey. This strategic move, backed by Cuadrilla Capital,...

Continue Reading
Empower Pharmacy Recognized Among Fastest Growing Companies

Updated Category News Views 126

Empower Pharmacy Recognized Among Fastest Growing Companies The recognition of Empower Pharmacy as No. 65 on the annual Inc. Regionals: Southwest list underscores its extraordinary journey in the healthcare sector. The companies that made this prestigious list experienced a median growth rate of an impressive 106 percent. This recognition not only highlights Empower’s...

Continue Reading
LightPath Technologies Secures $22.1 Million Order for IR Cameras

Updated Category News Views 188

LightPath Technologies Secures Major Purchase Order LightPath Technologies, Inc. (NASDAQ: LPTH), a pioneer in the field of next-generation optics and imaging systems, has recently announced the receipt of a significant follow-on purchase order worth $22.1 million. This order, connected to the supply of advanced infrared camera systems, builds on their previous arrangement...

Continue Reading
Canaan Inc. Sees Remarkable Growth in Q3 2025 Financials

Updated Category News Views 166

Canaan Inc. Financial Performance Overview Total revenues for Canaan Inc. reached US$150.5 million, a remarkable increase of 104.4% year-over-year. This growth surpassed initial guidance and highlighted the company's resilience and effectiveness in meeting market demand. Notably, Bitcoin mining revenues surged to US$30.6 million, showcasing an impressive year-over-year...

Continue Reading